Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
BSX · against 55 other Healthcare companies of similar size
Ranked #12 of 56 · scores higher than 78% of peers
Bars: peers in each 10-point band of the valuation score9 peers with a valuation score of 70–79, including BSX · Click a bar to see the companies
Mainly thanks to its earnings yield, EBITDA yield and free cash flow yield, which are stronger than most Healthcare peers.
| Metric | BSX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 54 reported | 5.7% | 3.0% | 87% | 30% | |
| EBITDA yieldHigher is better · 57 reported | 7.6% | 6.1% | 70% | 50% | |
| Free cash flow yieldHigher is better · 41 reported | 2.9% | 3.9% | 35% | 20% | |
| Book yieldHigher is better · 53 reported | 39.6% | 20.1% | 75% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 78.1B USD | 89 | 60 | |
| 2 | 108.6B USD | 88 | 66 | |
| 3 | 97.5B USD | 87 | 67 | |
| 4 | 6.17T JPY (≈$42.0B) | 86 | 70 | |
| 5 | 45.9B USD | 84 | 61 | |
| 6 | 34.3B USD | 83 | 57 | |
| 9 | 100.2B USD | 82 | 57 | |
| 10 | 89.7B USD | 76 | 50 | |
| 11 | 38.9B USD | 75 | 56 | |
| 12 | 63.0B USD | 74 | 65 | |
| 12 | 36.4B USD | 74 | 50 | |
| 14 | 534.1B HKD (≈$68.4B) | 72 | 75 | |
| 14 | 48.5B EUR (≈$53.4B) | 72 | 53 | |
| 16 | 11.26T JPY (≈$76.6B) | 71 | 72 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score